SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down‐regulation of MGMT. Issue 12 (7th November 2019)

• Record Type: Journal Article
• Authors: Tsai, Chia‐Kuang; Huang, Li‐Chun; Wu, Yi‐Ping; Kan, I‐Ying; Hueng, Dueng‐Yuan
• Is Part Of: FASEB journal. Volume 33:Issue 12(2019)
• Page Start: 14171
• Page End: 14184
• Publication Date: 2019-11-07
• Subjects: S‐nitroso‐N‐acetylpenicillamine -- NDRG1 -- apoptosis -- HIF‐1; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201901021RR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract : Glioblastoma multiforme (GBM) is the most frequently occurring and gravest primary tumor of the CNS in adults. The development of chemoresistance to temozolomide (TMZ), the first‐line chemotherapy for GBM, is an important factor contributing to poor treatment outcomes. Down‐regulation of O‐6‐methylguanine‐DNA methyltransferase (MGMT) expression in GBM cells is an attractive strategy for overcoming TMZ resistance and improving outcomes. This study revealed that the nitric oxide (NO) donor S‐nitroso‐N‐acetylpenicillamine (SNAP) exerts antitumorigenic effects on TMZ‐sensitive and TMZ‐resistant (TMZ‐R) glioma cells. Pretreatment with SNAP not only induced apoptosis, mitochondrial dysfunction, and hypoxia‐inducing factor 1, but also resensitized TMZ‐R GBM cells to TMZ through down‐regulation of MGMT expression. SNAP acted principally through post‐translational modification of p53, phosphorylated N‐myc downstream regulated gene 1, and MGMT protein stability in TMZ‐R GBM cells. Additionally, when applied together, SNAP and TMZ enhanced the inhibition of tumor growth in vitro and in vivo. This study sheds new light on a potential strategy to overcome TMZ resistance in GBM and thus possesses the potential for prolonging survival of patients with GBM.—Tsai, C.‐K., Huang, L.‐C., Wu, Y.‐P., Kan, I.‐Y., Hueng, D.‐Y. SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down‐regulation of MGMT. FASEB J. 33, 14171‐14184 (2019). www.fasebj.org